One of the few examples of COL1A1 downregulation in cancer was reported for hepatocellular carcinoma, where COL1A1 expression was significantly decreased in tumor tissue compared to adjacent normal tissue, with promoter hypermethylation identified as the silencing mechanism [79]. Here, COL1A1 is linked to cancer.